Protective Effects of the mTOR Inhibitor Everolimus on Cytoskeletal Injury in Human Podocytes Are Mediated by RhoA Signaling

Jeruschke, Stefanie; Büscher, Anja Katrin; Oh, Jun; Saleem, Moin Ahson; Hoyer, Peter Friedrich; Weber, Stefanie; Nalbant, Perihan
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Podocytes are highly differentiated kidney cells playing an important role in maintaining the glomerular filtration barrier. Particularly, the integrity of the actin cytoskeleton is crucial as cytoskeletal damage associated with foot process effacement and loss of slit diaphragms constitutes a major aspect of proteinuria. Previously, the mammalian target of rapamycin (mTOR) was linked to actin regulation and aberrant activity of the kinase was associated with renal disease. In this study, actin-related effects of mTOR inhibition by the immunosuppressant everolimus (EV) were investigated in human podocytes using an in vitro model of puromycin aminonucleoside (PAN) induced proteinuria. EV substantially recovered aberrant podocyte behavior by re-establishing a stationary phenotype with decreased migration efficiency, enhanced cell adhesion and recovery of actin stress fibers. Biochemical studies revealed substantial increase in the activity of RhoA and the effector pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC) by EV, all known regulators of stress fiber generation. Taken together, we show for the first time cytoskeleton stabilizing effects of the mTOR inhibitor EV and establish RhoA signaling as a key mediator in this process.


Related Articles

  • mTOR controls kidney epithelia in health and disease. Grahammer, Florian; Wanner, Nicola; Huber, Tobias B. // Nephrology Dialysis Transplantation;Feb2014, Vol. 29 Issue suppl_1, pi9 

    Renal epithelial function is the cornerstone of key excretory processes performed by our kidneys. Most of these tasks need to be tightly controlled to keep our internal environment in balance. Recently, the mTOR signalling network emerged as a key pathway controlling renal epithelial cells from...

  • Leptin Activates RhoA/ROCK Pathway to Induce Cytoskeleton Remodeling in Nucleus Pulposus Cells. Zheng Li; Jinqian Liang; William Ka Kei Wu; Xin Yu; Jun Yu; Xisheng Weng; Jianxiong Shen // International Journal of Molecular Sciences;Jan2014, Vol. 15 Issue 1, p1176 

    Hyperleptinemia is implicated in obesity-associated lumbar disc degeneration. Nevertheless, the effect of leptin on the intracellular signaling of nucleus pulposus cells is not clear. The current study sought to delineate the possible involvement of the RhoA/ROCK pathway in leptin-mediated...

  • The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury. Teng, Beina; Lukasz, Alexander; Schiffer, Mario // International Journal of Cell Biology;2012, p1 

    ADF/cofilins are the major regulators of actin dynamics in mammalian cells. The activation of ADF/cofilins is controlled by a variety of regulatory mechanisms. Dysregulation of ADF/cofilin may result in loss of a precisely organized actin cytoskeletal architecture and can reduce podocyte...

  • Intracellular Ca2+ signaling. Decuypere, Jean-Paul; Paudel, Ram Chandra; Parysu, Jan; Bultyncku, Geert // Communicative & Integrative Biology;Sep/Oct2013, Vol. 6 Issue 5, p1 

    Functional intracellular Ca2+ signaling is essential for the upregulation of the canonical mTOR-controlled autophagy pathway triggered by rapamycin or by nutrient deprivation. moreover, modifications in the Ca2+-signaling machinery coincide with autophagy stimulation. this results in enhanced...

  • Inhibition of Rac and ROCK Signalling Influence Osteoblast Adhesion, Differentiation and Mineralization on Titanium Topographies. Prowse, Paul D. H.; Elliott, Christopher G.; Hutter, Jeff; Hamilton, Douglas W. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Reducing the time required for initial integration of bone-contacting implants with host tissues would be of great clinical significance. Changes in osteoblast adhesion formation and reorganization of the F-actin cytoskeleton in response to altered topography are known to be upstream of...

  • Integrity of mTORC2 is dependent on the rictor Gly-934 site. Aimbetov, R; Chen, C-H; Bulgakova, O; Abetov, D; Bissenbaev, A K; Bersimbaev, R I; Sarbassov, D D // Oncogene;4/19/2012, Vol. 31 Issue 16, p2115 

    Growth factor signaling coupled to activation of the phosphatidylinositol-3-OH kinase (PI3K)/Akt pathway plays a crucial role in the regulation of cell proliferation and survival. The key regulatory kinase of Akt has been identified as mammalian target of rapamycin complex 2 (mTORC2), which...

  • EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry. Cornez, Isabelle; Joel, Mrinal; Taskén, Kjetil; Langmoen, Iver; Glover, Joel; Berge, Torunn // Journal of Neuro-Oncology;Apr2013, Vol. 112 Issue 1, p49 

    Development of novel patient stratification tools for cancer is a challenge that require advanced molecular screening and a detailed understanding of tumour signalling networks. Here, we apply phospho-specific flow cytometry for signal profiling of primary glioblastoma tumours after preservation...

  • Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Wen, Z-H; Su, Y-C; Lai, P-L; Zhang, Y; Xu, Y-F; Zhao, A; Yao, G-Y; Jia, C-H; Lin, J; Xu, S; Wang, L; Wang, X-K; Liu, A-L; Jiang, Y; Dai, Y-F; Bai, X-C // Oncogene;1/10/2013, Vol. 32 Issue 2, p160 

    The mammalian target of rapamycin (mTOR) signaling pathway is upregulated in the pathogenesis of many cancers. Arachidonic acid (AA) and its metabolites play critical role in the development of breast cancer, but the mechanisms through which AA promotes mammary tumorigenesis and progression are...

  • mTOR signaling in neural stem cells: from basic biology to disease. Magri, Laura; Galli, Rossella // Cellular & Molecular Life Sciences;Aug2013, Vol. 70 Issue 16, p2887 

    The mammalian target of rapamycin (mTOR) pathway is a central controller of growth and homeostasis, and, as such, is implicated in disease states where growth is deregulated, namely cancer, metabolic diseases, and hamartoma syndromes like tuberous sclerosis complex (TSC). Accordingly, mTOR is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics